(lp0
S'MediciNova Inc.  Moves Higher on Volume Spike for March 17 Equities.com - Mar 17, 2017 MediciNova Inc.  traded on unusually high volume on Mar. 17, as the stock gained 0.5% to close at $5.98. On the day, MediciNova Inc. saw 89,562 shares trade hands on 219 trades. Considering that the stock averages only a daily volume of 30,856&nbsp;...'
p1
aS'MediciNova Inc. MNOV  Wall Street Journal - Feb 11, 2011 News MediciNova Inc.MNOV. Significant News Only. 02/27/17; Press Release. MediciNova Announces MN-166  Glioblastoma Abstract Selected for Presentation at the 5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies&nbsp;...'
p2
aS'Chart Watch: Checking on Shares of MediciNova Inc  Davidson Register - 15 hours ago Technical traders have a large inventory of technical indicators they may use when doing technical stock analysis. After a recent look, the 14-day ATR for MediciNova Inc  is resting at 0.24. First developed by J. Welles Wilder, the ATR may help ...'
p3
aS'Stock Alert: MediciNova Inc Realized Volatility Hits A Substantially Lowered Level CML News - Mar 17, 2017 Before we cover the full analysis we make a quick alert here that MediciNova Inc  has seen its stock price move at a substantially lowered level.'
p4
aS'MediciNova Inc.  Soars 5.74% on February 27 Equities.com - Feb 27, 2017 MediciNova Inc.  had a good day on the market for Monday February 27 as shares jumped 5.74% to close at $6.45. About 58,763 shares traded hands on 511 trades for the day, compared with an average daily volume of 72,676 shares out of a total&nbsp;...'
p5
aS'MediciNova, Inc.  Valuation in Focus Business Review - Mar 18, 2017 The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.'
p6
aS'MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN ... GlobeNewswire  - Jul 24, 2016 LA JOLLA, Calif., July 24, 2016  -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market  and the JASDAQ Market of the Tokyo Stock Exchange , today announced&nbsp;...'
p7
aS"MediciNova's Ibudilast And The Phase IIb Trial Offer Steady Outlook Seeking Alpha - Jan 18, 2016 Recent news surrounding Medicinova's  progress has concerned its drug MN-166, or ibudilast, and its treatment of ALS, commonly known as Lou Gehrig's disease."
p8
aS'MediciNova Inc Stock Volatility Hits A Tumbling Low CML News - Mar 5, 2017 This is a proprietary realized volatility rating created by Capital Market Laboratories  based on a large number of data interactions for MediciNova Inc  . We examine the little used gem of daily stock volatility over a 20-day and ...'
p9
aS'MediciNova Announces MN-166  Glioblastoma Abstract Selected for ... GlobeNewswire  - Feb 27, 2017 LA JOLLA, Calif., Feb. 27, 2017  -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market  and the JASDAQ Market of the Tokyo Stock Exchange , today announced&nbsp;...'
p10
a.